Abstract:Fascinatingly, an abundance of recent studies has subscribed to the importance of cytotoxic immune mechanisms that appear to increase the risk/trigger for many progressive neurodegenerative disorders, including Parkinson's disease (PD), Alzheimer's disease (AD), amyotrophic lateral sclerosis, and multiple sclerosis. Events associated with the neuroinflammatory cascades, such as ageing, immunologic dysfunction, and eventually disruption of the blood–brain barrier and the "cytokine storm", appear to be orchestrated mainly through the activation of microglial cells and communication with the neurons. The inflammatory processes prompt cellular protein dyshomeostasis. Parkinson's and Alzheimer's disease share a common feature marked by characteristic pathological hallmarks of abnormal neuronal protein accumulation. These Lewy bodies contain misfolded α-synuclein aggregates in PD or in the case of AD, they are Aβ deposits and tau-containing neurofibrillary tangles. Subsequently, these abnormal protein aggregates further elicit neurotoxic processes and events which contribute to the onset of neurodegeneration and to its progression including aggravation of neuroinflammation. However, there is a caveat for exclusively linking neuroinflammation with neurodegeneration, since it's highly unlikely that immune dysregulation is the only factor that contributes to the manifestation of many of these neurodegenerative disorders. It is unquestionably a complex interaction with other factors such as genetics, age, and environment. This endorses the "multiple hit hypothesis". Consequently, if the host has a genetic susceptibility coupled to an age-related weakened immune system, this makes them more susceptible to the virus/bacteria-related infection. This may trigger the onset of chronic cytotoxic neuroinflammatory processes leading to protein dyshomeostasis and accumulation, and finally, these events lead to neuronal destruction. Here, we differentiate "neuroinflammation" and "inflammation" with regard to the involvement of the blood–brain barrier, which seems to be intact in the case of neuroinflammation but defect in the case of inflammation. There is a neuroinflammation-inflammation continuum with regard to virus-induced brain affection. Therefore, we propose a staging of this process, which might be further developed by adding blood- and CSF parameters, their stage-dependent composition and stage-dependent severeness grade. If so, this might be suitable to optimise therapeutic strategies to fight brain neuroinflammation in its beginning and avoid inflammation at all.

Understanding immune microenvironment alterations in the brain to improve the diagnosis and treatment of diverse brain diseases

CNS and CNS Diseases in Relation to Their Immune System

Meningeal Immunity and Neurological Diseases: New Approaches, New Insights

Exosomal Mirnas in Central Nervous System Diseases: Biomarkers, Pathological Mediators, Protective Factors and Therapeutic Agents.

Blood-derived factors to brain communication in brain diseases

The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases

Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases

Imaging of brain barrier inflammation and brain fluid drainage in human neurological diseases

New insight into neurological degeneration: Inflammatory cytokines and blood–brain barrier

Histological Architecture Underlying Brain-Immune Cell-Cell Interactions and the Cerebral Response to Systemic Inflammation

Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells

Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?

Immune-mediated disruption of the blood-brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets

Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms

Impact of gut-brain interaction in emerging neurological disorders

Species differences in immune‐mediated CNS tissue injury and repair: A (neuro)inflammatory topic

Age-Related Alterations in Peripheral Immune Landscape with Magnified Impact on Post-Stroke Brain

Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications

Frontiers of Neurodegenerative Disease Treatment: Targeting Immune Cells in Brain Border Regions

The Role of T-lymphocytes in Central Nervous System Diseases

Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view